Response Pharmaceuticals

Website

Developer an intestinal microsomal triglyceride transfer protein inhibitor designed to treat the metabolic side effects of antipsychotic drugs. The company develops treatments for post-prandial trigly...

Healthcare
Falls Church, VA, United States
Founded 2021
10 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$11.9M
Last Round
N/A
Investors
+5 other investors
View all 5 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Response Pharmaceuticals's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required